Some researchers have also proposed [16], hyperinsulinemia and IGF‐1 can alter the cell cycle regulation via the RAS/MAPK/ERK pathway, thereby promoting the growth, differentiation, and proliferation of tumor cells. The gene discussed is IGF1; the disease is hyperinsulinism.